Caution:At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
see.ip - Details for KOMBINATIONSTHERAPIE UMFASSEND EINEN MDM2-HEMMER UND EINEN ODER MEHRERE ZUSÄTZLICHE PHARMAZEUTISCHE WIRKSTOFFE ZUR BEHANDLUNG VON KREBS
Details for 2014805743
Up to date per 12.06.2026
Actions
Details for 2014805743
Title / Product Name
KOMBINATIONSTHERAPIE UMFASSEND EINEN MDM2-HEMMER UND EINEN ODER MEHRERE ZUSÄTZLICHE PHARMAZEUTISCHE WIRKSTOFFE ZUR BEHANDLUNG VON KREBS
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2014805743
EP Publication Number
3068393
E-Number
1473560
Language
EN
PCT Number
US14065034
Publication Date
21.09.2016 A
09.03.2022 B1
Registration Date
09.03.2022
AT Publication Date
15.03.2022
Application Date
11.11.2014
Registration Number
-
Priorities
11.11.2013
US
201361902717 P
IPC
A61K 31/451 20060101AFI20210902BHEP
Maximum Duration of Protection
11.11.2034
Owner
Amgen Inc.One Amgen Center Drive Thousand Oaks, California 91320-1799US
Representative
Representative
Dipl.-Ing. Mag. Michael BabelukFlorianigasse 26/31080 WienAT
Inventor
CAENEPEEL, Sean2090 Stonehill Circle Thousand Oaks, CA 91360US
CANON, Jude13240 Fiji Way, Unit A Marina Del Rey, California 90292US
HUGHES, Paul909 14th Street 1 Santa Monica, California 90403US
OLINER, Jonathan D.P.O Box 55 Garrett Park, MD 20896US
RICKLES, Richard J.10 Knowles Farm Road Arlington, Massachusetts 02474US
SAIKI, Anne Y.4473 Cedarglen Court Moorpark, California 93021US